These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25128091)

  • 1. Cellular immune response in patients with chronic hepatitis B virus infection.
    Li X; Wang Y; Chen Y
    Microb Pathog; 2014 Sep; 74():59-62. PubMed ID: 25128091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune response induced by hepatitis B virus principal antigens.
    Huang CF; Lin SS; Ho YC; Chen FL; Yang CC
    Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation and Exhaustion of Adaptive Immune Cells in Hepatitis B Infection.
    Gogoi D; Borkakoty B; Biswas D; Mahanta J
    Viral Immunol; 2015 Sep; 28(7):348-53. PubMed ID: 26331345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune tolerance against HBV can be overcome in HBV transgenic mice by immunization with dendritic cells pulsed by HBVsvp.
    Farag MM; Tedjokusumo R; Flechtenmacher C; Asen T; Stremmel W; Müller M; Protzer U; Weigand K
    Vaccine; 2012 Sep; 30(42):6034-9. PubMed ID: 22867720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
    Wang FS; Zhang Z
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBV and the immune response.
    Ferrari C
    Liver Int; 2015 Jan; 35 Suppl 1():121-8. PubMed ID: 25529097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune suppression in chronic hepatitis B infection associated liver disease: A review.
    Li TY; Yang Y; Zhou G; Tu ZK
    World J Gastroenterol; 2019 Jul; 25(27):3527-3537. PubMed ID: 31367154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Tim-3 in hepatitis B virus infection: An overview.
    Liu Y; Gao LF; Liang XH; Ma CH
    World J Gastroenterol; 2016 Feb; 22(7):2294-303. PubMed ID: 26900291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F; Loggi E; Chisholm JV; Biselli M; Morelli MC; Cursaro C; Terrault NA; Bernardi M; Bertoletti A; Andreone P; Brander C
    Liver Transpl; 2008 Apr; 14(4):478-85. PubMed ID: 18324666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection.
    Zhang Z; Zhang JY; Wang LF; Wang FS
    J Gastroenterol Hepatol; 2012 Feb; 27(2):223-30. PubMed ID: 22004062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
    Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
    Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
    Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of hepatitis B virus infection: an update for clinicians.
    Pungpapong S; Kim WR; Poterucha JJ
    Mayo Clin Proc; 2007 Aug; 82(8):967-75. PubMed ID: 17673066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunopathogenesis of HBV infection.
    Koziel MJ
    Antivir Ther; 1998; 3(Suppl 3):13-24. PubMed ID: 10726052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus immunopathogenesis.
    Chisari FV; Ferrari C
    Annu Rev Immunol; 1995; 13():29-60. PubMed ID: 7612225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.
    Chen Y; Li X; Ye B; Yang X; Wu W; Chen B; Pan X; Cao H; Li L
    Antiviral Res; 2011 Jul; 91(1):23-31. PubMed ID: 21549152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.
    Zerbini A; Pilli M; Boni C; Fisicaro P; Penna A; Di Vincenzo P; Giuberti T; Orlandini A; Raffa G; Pollicino T; Raimondo G; Ferrari C; Missale G
    Gastroenterology; 2008 May; 134(5):1470-81. PubMed ID: 18355815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins.
    Safadi R; Israeli E; Papo O; Shibolet O; Melhem A; Bloch A; Rowe M; Alper R; Klein A; Hemed N; Segol O; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Am J Gastroenterol; 2003 Nov; 98(11):2505-15. PubMed ID: 14638356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.